Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Mar 2024 |
|---|---|---|---|---|
| Total reported revenue | 3.6B | 2.9B | 3.4B | 2.9B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 33M | 60M | 48M | 39M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | 0 | 0 | 0 | 0 |
| Pretax income | 962M | 375M | 756M | 573M |
| Tax provision | 221M | 127M | 174M | 117M |
| Net income | 740M | 248M | 582M | 456M |
| Basic EPS | 9 | 3 | 7.1 | 5.5 |
| Diluted EPS | 9 | 3 | 7.1 | 5.5 |
| Basic average shares | 82.2M | 82.7M | 81.8M | 82.9M |
| Diluted average shares | 82.2M | 82.7M | 81.8M | 82.9M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |